Westwood Holdings Group Inc. raised its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH – Free Report) by 0.1% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 908,460 shares of the company’s stock after purchasing an additional 1,205 shares during the period. Westwood Holdings Group Inc. owned 1.83% of Prestige Consumer Healthcare worth $62,547,000 at the end of the most recent reporting period.
A number of other large investors also recently bought and sold shares of PBH. Congress Wealth Management LLC DE boosted its holdings in Prestige Consumer Healthcare by 246.1% in the fourth quarter. Congress Wealth Management LLC DE now owns 114,220 shares of the company’s stock valued at $6,993,000 after acquiring an additional 81,215 shares during the last quarter. The Manufacturers Life Insurance Company raised its stake in shares of Prestige Consumer Healthcare by 5.3% in the 4th quarter. The Manufacturers Life Insurance Company now owns 605,376 shares of the company’s stock valued at $37,061,000 after acquiring an additional 30,288 shares during the period. State Board of Administration of Florida Retirement System lifted its holdings in shares of Prestige Consumer Healthcare by 77.4% during the 1st quarter. State Board of Administration of Florida Retirement System now owns 25,221 shares of the company’s stock valued at $1,830,000 after acquiring an additional 11,000 shares in the last quarter. Congress Asset Management Co. MA boosted its position in Prestige Consumer Healthcare by 596.2% during the 4th quarter. Congress Asset Management Co. MA now owns 679,256 shares of the company’s stock worth $41,584,000 after purchasing an additional 581,685 shares during the period. Finally, Norges Bank acquired a new stake in Prestige Consumer Healthcare in the 4th quarter valued at $27,739,000. Hedge funds and other institutional investors own 99.95% of the company’s stock.
Prestige Consumer Healthcare Stock Performance
Shares of PBH stock opened at $73.01 on Friday. The firm has a market capitalization of $3.62 billion, a P/E ratio of 17.51, a P/E/G ratio of 2.08 and a beta of 0.48. Prestige Consumer Healthcare Inc. has a 12 month low of $56.34 and a 12 month high of $75.80. The company has a debt-to-equity ratio of 0.65, a current ratio of 3.23 and a quick ratio of 1.90. The company’s fifty day moving average price is $71.22 and its two-hundred day moving average price is $69.67.
Analyst Ratings Changes
Separately, DA Davidson increased their target price on Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a “buy” rating in a research note on Wednesday, August 28th. One equities research analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat.com, Prestige Consumer Healthcare presently has a consensus rating of “Moderate Buy” and an average target price of $98.75.
Check Out Our Latest Stock Report on Prestige Consumer Healthcare
Prestige Consumer Healthcare Profile
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.
Read More
- Five stocks we like better than Prestige Consumer Healthcare
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- Investing In Preferred Stock vs. Common Stock
- MarketBeat Week in Review – 9/16 – 9/20
- 3 Best Fintech Stocks for a Portfolio Boost
- Don’t Miss These 3 Retail Stocks for Fall Gains
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.